Stockscreener 앱 받기
1.915
3.54%
-0.065
Spero Therapeutics Inc 주식(SPRO)의 최신 뉴스
Is Spero Therapeutics Inc. gaining market share2025 Volume Leaders & Risk Adjusted Buy/Sell Alerts - newsyoung.net
Price Consolidation Hints at Upcoming Move in Spero Therapeutics Inc.July 2025 Pullbacks & Fast Entry Momentum Trade Alerts - newsyoung.net
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2025 Earnings Call Transcript - Insider Monkey
Spero Therapeutics Inc (SPRO) Q2 2025 Earnings Call Highlights: Tepipenem HBR Trial Success and ... - Yahoo Finance
Spero Therapeutics Q2 2025 Earnings Call: Tepipenem HBR Success, Financial Improvements, and SPR 720 Disappointment - AInvest
Spero Therapeutics Inc (SPRO) Q2 2025 Earnings Call Highlights: - GuruFocus
Spero Therapeutics Q2 2025 Earnings Report - MarketBeat
Spero Therapeutics 2025 Q2 Earnings Strong Performance as Net Loss Declines 90.5% - AInvest
Spero Therapeutics' Q2 2025 Earnings: A Pivotal Moment for Antibiotic Innovation and Shareholder Value - AInvest
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update - GlobeNewswire
Earnings call transcript: Spero Therapeutics beats Q2 2025 forecasts, stock rises - Investing.com Nigeria
Earnings call transcript: Spero Therapeutics beats Q2 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Spero Therapeutics earnings beat by $0.54, revenue topped estimates - Investing.com Canada
Spero's Oral Antibiotic Shows Promise in Reducing Hospital Stays for UTI Patients - Stock Titan
Using Python tools to backtest Spero Therapeutics Inc. strategiesDay Trading Setup and Momentum Analysis - Newser
Spero Therapeutics SPRO 2025Q2 Earnings Preview Upside Anticipated on Drug Pipeline Expansion - AInvest
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025 - The Globe and Mail
Spero leads infectious disease gains with 252% stock jump - BioWorld MedTech
Biotech Co. AIRNA Adds Ex-Spero Legal Chief As Its 1st CLO - Law360
Spero Therapeutics to Report Second Quarter 2025 Financial - GlobeNewswire
Spero Q2 2025 Earnings: Rare Disease and MDR Treatment Pipeline Updates Coming August 12 - Stock Titan
How does Spero Therapeutics Inc. generate profit in a changing economyGet alerts on high-potential stock breakouts - Jammu Links News
What drives Spero Therapeutics Inc. stock priceInvest confidently with proven investment plans - Jammu Links News
Is Spero Therapeutics Inc. stock overvalued or undervaluedOverwhelming profit margins - Jammu Links News
Is it the right time to buy Spero Therapeutics Inc. stockUnlock superior stock analysis tools - Jammu Links News
Should I hold or sell Spero Therapeutics Inc. stock in 2025Achieve breakthrough investment performance - Jammu Links News
What catalysts could drive Spero Therapeutics Inc. stock higher in 2025Get exclusive access to expert stock recommendations - Jammu Links News
Spero Therapeutics Inc. Stock Analysis and ForecastExceptional trading results - Jammu Links News
What are the latest earnings results for Spero Therapeutics Inc.Exceptional financial outcomes - Jammu Links News
How volatile is Spero Therapeutics Inc. stock compared to the marketTremendous growth potential - Jammu Links News
What institutional investors are buying Spero Therapeutics Inc. stockCapitalize on emerging industry trends - Jammu Links News
How many analysts rate Spero Therapeutics Inc. as a “Buy”Free Smart Trading Workshop - Jammu Links News
Spero Therapeutics Inc. Stock Support and Resistance Levels You Should KnowInvestment Roadmap for High Potential Stocks - Newser
Trend analysis for Spero Therapeutics Inc. this weekSmart Chart Forecasting with AI Algorithms - Newser
How hedge fund analytics apply to Spero Therapeutics Inc. stockPattern Breakout Prediction for Short Term - Newser
Spero Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingProfit Target Stock Opportunity Monitor Activated - metal.it
Spero Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
What momentum shifts mean for Spero Therapeutics Inc.Predictable Income Summary for Long-Term Trades - Newser
Spero Therapeutics SPRO 2025Q2 Earnings Preview Upside Ahead on Strong Revenue Growth Prospects - AInvest
What is the risk reward ratio of investing in Spero Therapeutics Inc. stockPre Market Trend Scanner With High Returns - jammulinksnews.com
How Spero Therapeutics Inc. stock performs during market volatilitySmart Trade Forecast Based on Neural Logic - Newser
Spero Therapeutics Inc. Matches Institutional Buying FilterAccurate Buy Point for Momentum Stocks Detected - metal.it
What makes Spero Therapeutics Inc. stock price move sharplyFree Real Time Stock Movement Analysis - Newser
Multi factor analysis applied to Spero Therapeutics Inc.Free Weekly Setup With 3x Return Potential - Newser
Can Spero Therapeutics Inc. Regain Momentum After BreakdownWeekly Top Gainers Forecast Watchlist Released - beatles.ru
Will Spero Therapeutics Inc. stock benefit from AI tech trendsAI Triggered Buy Zone Forecast System - Newser
Why is Spero Therapeutics Inc. stock attracting strong analyst attentionSwing Trade Review With Proven Results - Jammu Links News
0.37%
0.57%
자본화:
|
볼륨(24시간):